Older stock news and analysis, organized by date. Back to latest news
Everest Group stock edges down despite Q1 earnings beat as revenue miss signals execution challenges despite profit strength.
eBay surges 3.4% after Q1 earnings beat, despite headwinds from earnings decline offsetting better-than-expected revenue.
Cognizant stock slips after Q1 beat as management issues cautious forward guidance amid IT budget uncertainty.
Carpenter stock dips 5% despite Q3 earnings beat and margin expansion as aerospace demand drives record profitability.
Chipotle stock surges after Q1 revenue beat, driven by unexpected comparable-restaurant sales growth.
C.H. Robinson beat Q1 EPS estimates despite reporting revenue below expectations, signaling cost discipline amid sector weakness.
Biogen jumped 6% after delivering a strong Q1 with broad-based product sales growth, led by Alzheimer's disease franchises.
American Water reported a Q1 earnings miss, though the company reaffirmed full-year guidance and raised its dividend.
Amphenol surged 3.24% on strong Q1 results, delivering 49.1% revenue growth and exceptional earnings expansion.
Amazon reported strong Q1 results with robust cloud revenue, though stock reaction remained muted despite earnings beat.
Allstate beat Q1 2026 revenue estimates and delivered EPS of $10.65, well above analyst expectations. Net income reached $2.46B as the stock trades near its 52-week high.
ALGN delivered a 12.8% EPS surprise in Q1 2026, with revenue up 6.2% YoY to $1.04B. Shares climbed over 5% in after-hours trading.
Aflac topped revenue estimates in Q1 2026 but fell short on EPS. Analyst sentiment has shifted notably more cautious in recent months.
Automatic Data Processing topped Q3 estimates with $3.63B in revenue and 7% growth, prompting management to raise its FY26 guidance.
AbbVie lifted its 2026 EPS guidance to $14.28 after Q1 EPS of $2.65 and $15B in revenue topped estimates, driven by Skyrizi and Rinvoq strength.
A roundup of today's most significant stock moves and news across the market.
FTAI plunges 6% to $216 on portfolio rotation pressure, masking robust 32.7% revenue growth and 29.8% earnings growth.
ETSY jumped on Q1 beat and steady demand, but shares fell 2.92% intraday as the forward P/E of 10.9x signals the market has already priced in recovery.
ETR gains traction after Q1 beat and long-term guidance hike, though elevated P/E of 28.9x signals premium pricing in the utility sector.
EG climbs 1.03% with a forward P/E of just 5.7x, the lowest among major insurance and business services peers, as Q1 results loom.
UBS lifted its price target to $110, signaling confidence in the marketplace ahead of earnings despite macro uncertainty.
Cognizant slipped on Q1 revenue miss and Q2 guidance below estimates, signaling cautious IT spending—offset partially by strategic $600M Astreya AI acquisition.
Carpenter Technology delivered Q3 FY2026 results with 25.9% earnings growth, though valuation at 49.7x trailing P/E suggests premium pricing.
Chipotle stock dipped 2.29% despite Wall Street optimism on its growth recipe, with FY earnings up just 4% and revenue growth at 4.9%.
Biogen shares rose 1.50% after beating Q1 revenue estimates, but management slashed full-year adjusted EPS guidance to $14.25–$15.25, signaling caution ahead.
Amphenol reports record first-quarter results with management signaling continued sales momentum through Q2 on broad end-market strength.
Amazon shares edge lower but hold near all-time highs. Analyst consensus remains firmly bullish as hyperscaler cloud spending faces a key market test.
ALL shares climb to $216.40, near their 52-week peak, as analyst consensus stays bullish ahead of Q1 results. Fundamentals show 103% EPS growth YoY and a 5.7x trailing P/E.
AFL shares climbed to $116.29 as Q1 results approach. Analyst consensus leans toward Hold amid declining revenue and net income growth.
ADP posted Q3 revenue of $5.94B and EPS of $3.37, beating estimates. Shares rallied over 4% as the company lifted its full-year 2026 forecast.
AbbVie topped Q1 2026 EPS estimates and lifted its full-year profit outlook, driven by immunology and neuroscience portfolio growth.
Utility reports top-line beat but bottom-line miss; reaffirms full-year guidance amid regulatory pressures.
Self-storage REIT beats Q1 estimates but cuts full-year FFO guidance as demand softens, sending cautionary signal.
Apartment REIT rallies 4.30% after Q1 core FFO beat, signaling operational momentum in tight rental markets.
Apartment REIT beats stock expectations with 4.54% gain after reporting mixed first-quarter earnings.
Solar inverter maker stumbles on weak demand despite developing solid-state transformer for AI data centers.
Edison International tops EPS estimates despite Q1 revenue shortfall, signaling operational strength amid regulatory pressures.
Ecolab delivers modest 4.8% revenue growth and 20.2% earnings expansion in Q1 despite gross margin compression.
CoStar delivers 23% revenue growth and $67M in annualized net new bookings despite a 0.77% stock decline.
Centene stock jumps 13.95% following Q1 results driven by strong revenue growth and positive Medicaid trends.
CMS Energy reports Q1 earnings while Michigan data center demand reshapes the utility's growth outlook.
CCEP gains 1.13% on strong earnings growth despite minimal revenue expansion, signaling margin improvement.
BXP stock rises 1.95% on Q1 beat and strong 2026 FFO guidance, buoyed by AI company leasing demand.
Booking beats on profit with 16% revenue growth, but geopolitical risks cloud near-term travel demand outlook.
Franklin Resources surges 6.86% on Q2 earnings beat and 60.6% earnings growth, signaling stronger profitability recovery.
Bloom Energy crushes Q1 forecasts with 130% revenue growth and raises full-year guidance, though stock dips 3.5% post-announcement.
AVY delivered adjusted EPS of $2.47 in Q1 2026, up 7% year-over-year, driven by volume gains and disciplined cost control. Shares trade at $166.49.
Allegion reported ~10% Q1 revenue growth but shares fell sharply. An ERP-related disruption in its international mechanical business offset solid Americas momentum.
AIT delivered its strongest organic sales growth in over two years in Q3 2026, driving record quarterly EBITDA. Shares touched a new 52-week high.
Arch Capital beat Q1 2026 EPS estimates with $2.50, driven by strong underwriting income and a sharp drop in catastrophe losses. Shares trade near $97.
A roundup of today's most significant stock moves and news across the market.
KO's Q1 earnings beat and raised profit guidance sent shares higher, offsetting broader market weakness.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.